Back to Natixis Natixis

IMNMIMNM

Showing 2 of 6 quarters

Position history for NatixisNatixis's holdings in Immunome, Inc.

No. Natixis exited its IMNM (Immunome) position in Q3 2025. Its Q2 2025 13F listed 229,305 shares worth $2.1M. Natixis first reported IMNM in Q4 2022 and held it in 4 quarterly 13F filings.

Final Value

$0

Final Shares

0

Total Value Change

-$2.1M

Total Shares Change

-229,305

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2025-Q3
Latest
Exited
0
-100.0%
$00.0%$11.71
0
2025-Q2
New
229,305
—
$2.1M0.0%$9.30
36

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used